National Vision Holdings, Inc. EYE
National Vision Holdings, Inc. (EYE) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the distress zone. It pays a dividend yielding 11.32% (safety: no dividend). FY2026 revenue was $2.0B at a 1.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.094 |
| Retained earnings / assets | 0.129 |
| EBIT / assets | 0.03 |
| Equity / liabilities | 0.78 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| EYE | National Vision Holdings, Inc. | 7/9 | 0.82 | 51 | +9% |
| WRBY | Warby Parker Inc. | 5/9 | -0.22 | — | +13% |
| STAA | STAAR SURGICAL CO | 1/9 | 4.46 | — | -23.7% |
| RXST | RxSight, Inc. | 2/9 | 5.56 | — | -3.9% |
| LUCY | Innovative Eyewear Inc | 4/9 | — | — | — |
| COO | COOPER COMPANIES, INC. | 6/9 | 4.99 | 36.9 | +5.1% |
| BLCO | Bausch & Lomb Corp | 3/9 | 1.24 | — | +6.5% |
About National Vision Holdings, Inc.
National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company offers eyeglasses and contact lenses, and optical accessory products; and provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, Vista Optical military, and DiscountContacts.com. It also offers health maintenance organization and optometric services. In addition, the company sells prescription and non-prescription eyewear, contact lenses and related accessories to retail customers. The company serves a diverse customer base, including price-driven consumers, style leaders, wellness shoppers with vision benefits, managed care customers, outside prescription customers, and progressive lens wearers. The company was formerly known as National Vision, Inc. and changed its name to National Vision Holdings, Inc. in March 2014. The company was founded in 1990 and is headquartered in Duluth, Georgia.
FAQ
Is EYE financially healthy?
National Vision Holdings, Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does EYE pay a dividend, and is it safe?
Yes. National Vision Holdings, Inc. pays a dividend yielding about 11.32% with a None payout ratio, rated “no dividend” for safety.
How profitable is EYE?
In FY2026, National Vision Holdings, Inc. had a net margin of 1.5% and a return on equity of 3.4%.
Is EYE overvalued or undervalued?
National Vision Holdings, Inc. trades at about 52.7× trailing earnings — below its 10-year norm (10-year range 28.6×–105.9×, median 79.0×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for EYE?
The average Wall-Street price target for National Vision Holdings, Inc. is $29.27, about 50.0% above the recent price, from 11 analysts.
Is EYE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on National Vision Holdings, Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the distress zone, a P/E of about 51.0×, a dividend yield of 11.32%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-01-03. Facts plus Stocktoria's own computed scores — not investment advice.